These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1021 related items for PubMed ID: 6460854
1. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication. Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M. J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854 [Abstract] [Full Text] [Related]
2. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions. Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y. Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350 [Abstract] [Full Text] [Related]
3. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison. Lantto T, Vorne M, Mokka R, Vähätalo S. Acta Radiol; 1987 Feb; 28(5):631-3. PubMed ID: 2960361 [Abstract] [Full Text] [Related]
4. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication. Mele M, Conte E, Fratello A, Pasculli D, Pieralice M, D'Addabbo A. J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136 [Abstract] [Full Text] [Related]
8. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios. Buell U, Kirsch CM, Kleinhans E, Jäger B. J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711 [No Abstract] [Full Text] [Related]
9. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases. Pauwels EK, Blom J, Camps JA, Hermans J, Rijke AM. Eur J Nucl Med; 1983 Dec; 8(3):118-22. PubMed ID: 6220908 [Abstract] [Full Text] [Related]
10. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)? Frühling J, Verbist A, Balikdjian D. Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485 [Abstract] [Full Text] [Related]
11. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication. Van Duzee BF, Schaefer JA, Ball JD, Chilton HM, Cowan RJ, Kuni C, Trow R, Watson NE. J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404 [Abstract] [Full Text] [Related]
13. A clinical comparison of MDP and DMAD. Rosenthall L, Stern J, Arzoumanian A. Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358 [Abstract] [Full Text] [Related]
14. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging? Kumar V, Kumar D, Howman-Giles RB, Little DG. Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350 [Abstract] [Full Text] [Related]
18. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate]. Otsuka N, Yoneda M, Sawai M, Saito J, Nagai K, Muranaka A, Terashima H, Yanagimoto S, Ito Y. Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135 [No Abstract] [Full Text] [Related]
19. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. Fogelman I, Pearson DW, Bessent RG, Tofe AJ, Francis MD. J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135 [Abstract] [Full Text] [Related]
20. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG). Pauwels EK, Camps JA, Blom J, Hermans J, Kelly JD, Cumming SA, Blackburn GM, Rashid A. Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848 [Abstract] [Full Text] [Related] Page: [Next] [New Search]